# Phase B Completion — Look-Ahead & Timestamp Audit

**Date:** 2026-07-25  
**Scope:** Final Phase B code, frozen task packet, persisted audits, 60 monthly artifact partitions, correction journals, global integrity result, runtime-parity evidence, and boundary-continuity evidence  
**Auditor:** lookahead-auditor v1  
**Scope hash:** `dcafc373389be07693337349044bf33a04d9e626c437f862e365c6e7d44d707b`  
**Verdict:** **PASS — Phase B is complete; Phase C may begin**

## Summary

- Critical: 0
- Warning: 0
- Note: 0

## Findings

None.

## Acceptance evidence

- Exactly 60 complete monthly partitions cover January 2021 through December 2025.
- All partitions use the canonical four-day causal warmup and sealed boundary.
- Checkpoints, regimes, features, availability, and scores were generated in NautilusTrader.
- Emission is independent of future flips, labels, selection, and outcomes.
- The final population contains 5,665,103 score rows, 2,880,577 missing-dispatch rows, and 137,961 unique flips.
- Score and missing keys exactly reconcile to the canonical five-second RTH grid in every partition.
- Global integrity reports PASS with no failures.
- Bullish and Bearish runtime feature/vector/probability parity is exact.
- Rank fields remain null; no overlapping-reference threshold was applied during Phase B.
- Four-day versus long-prefix boundary continuity passes across year and DST cases.
- All partitions share one historical runtime identity, config hash, and catalog identity.
- All artifact hashes, label-finalization identities, correction journals, and global aggregates reconcile.
- Post-run collector fixes preserve historical provenance and prevent mixed-code resume.

## Compliance matrix

| Rule | Status |
|---|---|
| A1–A5 | PASS |
| B1–B7 | PASS |
| C1–C4 | PASS/N/A |
| D1 | PASS |
| D2 | N/A |
| D3–D4 | PASS |
| E1–E2 | PASS |
| E3–E4 | N/A |
| E5 | PASS |
| F1–F4 | PASS |
| G1–G3 | PASS |
| G4 | N/A |
| H1–H4 | N/A |

*Read-only completion audit complete. Phase B satisfies the frozen acceptance contract with zero critical and zero warning findings. Phase C is authorized to begin.*
